Jump to page content

nTTP-GCT-Tandems (Cohort 2026)

At the end of 2025, the decision was made to fund six additional tandems, which will start the program in spring 2026. The tandem partners come from Tübingen, Heidelberg, Greifswald, Hanover, and Berlin and introduce themselves and their projects below.

Dr. med. Carolin Blumendeller & Dr. rer. nat. Philip Bucher

 

 

GCT-Project:

Development of a novel base editing platform for tandem
CAR T cell therapy against pediatric neuroblastoma

More Information

Dr. med. Julia Unglaub & Dr. rer. nat. Dominic Alexej Depke

 

 

GCT-Project:

Engineering and optimization of CD96-specific CAR T cells: Advancing a novel immunotherapeutic strategy for patients with acute myeloid leukemia without HSPC toxicity

More Information

PD Dr. med. habil. Florian Siegerist & Dr. rer. nat. Tim Lange

 

 

GCT-Project:

Targeted mRNA Delivery via Exosomes for Cell-Specific Therapy in Kidney Disease

More Information

Dr. med. Elisa Marlene Henze & Dr. rer. nat. Anna Christina Dragon

 

 

GCT-Project:

CD176-CAR-T cells to treat multiple hematological and solid cancers – Definition of suitable patient cohorts

 

More Information

Dr. med. Nils Haep & Dr. rer. nat. Fabian Bachinger

 

 

GCT-Project:

Hepatocyte Transplantation in ex-vivo Perfused Livers for Organ Reconditioning

More Information

Dr. med. Marius Leye & Dr. rer. nat. Julia Ritterhoff

 

 

GCT-Project:

Novel Cardio-Specific Gene Therapy Strategies for Heart Failure

More Information